Early research (Phase 1)Not Yet RecruitingNCT07113496
What this trial is testing
RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies
Who this might be right for
Relapsed or Refractory B-cell Hematologic MalignanciesB-cell Acute Lymphoblastic Leukemia (B-ALL)Multiple Myeloma (MM)+3 more
The First Affiliated Hospital with Nanjing Medical University 27